Our most-read ophthalmology coverage of 2025 highlights how innovation continues to improve both diagnosis and treatment. From expert perspectives on the evolving therapeutic landscape in age-related macular degeneration to growing evidence supporting anterior segment OCT as a versatile, noninvasive tool in glaucoma triage and complex strabismus surgery planning, these articles reflect technology-driven gains in patient care.
Innovations in AMD treatment have improved outcomes
February is Age-Related Macular Degeneration Awareness Month. Ophthalmology 360 Editorial Advisory Board member Rohit Ross Lakhanpal, MD, of the Retina Care Center in Baltimore, talks about the treatments advancements that have been made for AMD and what his top treatment choice is for this patient population.
Watch the full video here.
AS-OCT shown to be a reliable alternative to gonioscopy for angle triage
Specialist-reviewed AS-OCT may serve as a safe and effective triage alternative to gonioscopy for angle assessment in virtual glaucoma clinics, according to a real-world study. With high sensitivity and strong predictive value for identifying open angles, AS-OCT could help streamline referrals and optimize in-person care when interpreted by glaucoma subspecialists.
Read the full article here.
Anterior segment OCT accurately measures muscle insertion in strabismus reoperations
Anterior segment OCT may provide a reliable, noninvasive way to localize previously operated horizontal rectus muscles before strabismus reoperations, according to a study. Preoperative ASOCT measurements closely matched intraoperative findings, demonstrating high accuracy and agreement, and suggesting a valuable role when prior surgical details are unclear or scarring limits visualization.
Read the full article here.
Related Content
